Key Insights

Highlights

Success Rate

90% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

7.2%

5 terminated out of 69 trials

Success Rate

89.6%

+3.0% vs benchmark

Late-Stage Pipeline

9%

6 trials in Phase 3/4

Results Transparency

19%

8 of 43 completed with results

Key Signals

8 with results90% success

Data Visualizations

Phase Distribution

66Total
Not Applicable (40)
Early P 1 (1)
P 1 (8)
P 2 (11)
P 3 (3)
P 4 (3)

Trial Status

Completed43
Recruiting8
Terminated5
Not Yet Recruiting5
Unknown5
Withdrawn2

Trial Success Rate

89.6%

Benchmark: 86.5%

Based on 43 completed trials

Clinical Trials (69)

Showing 20 of 20 trials
NCT07737951Not ApplicableNot Yet Recruiting

Tai Chi for Reducing Aromatase Inhibitor-Induced Arthralgia

NCT03180294Phase 2Completed

Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer

NCT07377383Not ApplicableRecruitingPrimary

Cardiometabolic Adaptations to Concurrent Training: Effect of Effort Configuration on Postmenopausal Women

NCT06445842Not ApplicableRecruitingPrimary

Short-term Circuit Training on Muscle Mass and Quality of Life in Sedentary Postmenopausal Women

NCT07615790Not ApplicableRecruitingPrimary

Structured Combined Exercise Program in Postmenopausal Women: Effects on Heart Rate Variability and Menopausal Symptoms

NCT07608042Not ApplicableEnrolling By Invitation

Lung Boost Therapy on Post-mastectomy Postmenopausal

NCT05544357Not ApplicableCompletedPrimary

Cardiovascular Adaptations to Resistance Exercise: Effect of Set Configuration on Postmenopausal Women

NCT07131215Not ApplicableRecruitingPrimary

Smart Technology-Based Intervention and Monitoring of Physical and Mental Health in Early Postmenopausal Women

NCT06821841Not ApplicableCompleted

Online Physical Activity Intervention for Peri- and Post-menopausal Working Women

NCT02860000Phase 2Completed

Alisertib With or Without Fulvestrant in Treating Patients With Locally Advanced or Metastatic, Endocrine-Resistant Breast Cancer

NCT07407699Not ApplicableNot Yet Recruiting

Exercise, Insulin Resistance, and Chronic Pain in Postmenopausal Women.

NCT07376408Not Yet RecruitingPrimary

Spousal Support and Sexual Quality of Life in Postmenopausal Women

NCT07324668Not ApplicableNot Yet Recruiting

Effects of Multiple Intervention on Postmenopausal Women With UI

NCT07302191Not ApplicableCompleted

High-Intensity Interval or Concurrent Exercise on Oxidative Stress and Inflammation in Obese Women

NCT06228768Not ApplicableCompletedPrimary

Acupressure for Aromatase Inhibitor-Associated Musculoskeletal Symptoms in Patients With Breast Cancer

NCT07052279Not ApplicableRecruiting

Water Based Burpee Exercises on Functional Capacity in Poste-menopausal Women After Thyroidectomy

NCT06908707Phase 1CompletedPrimary

A Study to Investigate Safety, Tolerability and Pharmacokinetics of LAE102 in Postmenopausal Women

NCT06866743CompletedPrimary

How Seasons Affect Kidney Health in Post-Menopausal Females

NCT07065526Not ApplicableCompletedPrimary

Application of EFT in Postmenopausal Women

NCT03953157Not ApplicableCompleted

Dietary and Exercise Interventions in Reducing Side Effects in Patients With Stage I-IIIa Breast Cancer Receiving Aromatase Inhibitors

Scroll to load more

Research Network

Activity Timeline